Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;129(3):290-303.
doi: 10.1111/bju.15601. Epub 2021 Nov 3.

Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy

Jordan G Flitcroft  1 , Jeroen Verheyen  2 , Tarun Vemulkar  1 , Emma N Welbourne  1 , Sabrina H Rossi  2 , Sarah J Welsh  2 , Russell P Cowburn  1 , Grant D Stewart  2
Affiliations
Review

Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy

Jordan G Flitcroft et al. BJU Int. 2022 Mar.

Abstract

Objectives: To review urinary protein biomarkers as potential non-invasive, easily obtainable, early diagnostic tools in renal cell carcinoma (RCC).

Methods: A PubMed database search was performed up to the year 2020 to identify primary studies reporting potential urinary protein biomarkers for RCC. Separate searches were conducted to identify studies describing appropriate methods of developing cancer screening programmes and detection of cancer biomarkers.

Results: Several urinary protein biomarkers are under validation for RCC diagnostics, e.g. aquaporin-1, perilipin-2, carbonic anhydrase-9, Raf-kinase inhibitory protein, nuclear matrix protein-22, 14-3-3 Protein β/α and neutrophil gelatinase-associated lipocalin. However, none has yet been validated or approved for clinical use due to low sensitivity or specificity, inconsistencies in appropriate study design, or lack of external validation.

Conclusions: Evaluation of biomarkers' feasibility, sample preparation and storage, biomarker validation, and the application of novel technologies may provide a solution that maximises the potential for a truly non-invasive biomarker in early RCC diagnostics.

Keywords: #KidneyCancer; #kcsm; #uroonc; biomarkers; early detection; kidney cancer; proteins; renal cell carcinoma; urinary; urine.

PubMed Disclaimer

References

    1. Chinello C, Cazzaniga M, De Sio G et al. Urinary signatures of renal cell carcinoma investigated by peptidomic approaches. PLoS One 2014; 9: e106684
    1. Cancer Research UK (CRUK) Kidney cancer incidence statistics. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s.... Accessed October 2020.
    1. Rossi SH, Blick C, Handforth C, Brown JE, Stewart GD. Essential research priorities in renal cancer: a modified Delphi consensus statement. Eur Urol Focus 2020; 6: 991-8
    1. Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol 2018; 36: 1341-53
    1. Zhou Y, Funston G, Lyratzopoulos G, Walter FM. Improving the timely detection of bladder and kidney cancer in primary care. Adv Ther 2019; 36: 1778-85

Publication types